We guarantee the lowest price on all of our prescription products. If you find your medications cheaper at any other recognized licensed mail order pharmacy, we will not only match their price, we will beat it by 25% of the difference. It is our 125% price match guarantee!
Example: If you find a product on Canada Drugs Direct for $50.00 and find the same product for $40.00 at another mail order pharmacy, we will provide you with a $12.50 discount, bringing your total to $37.50.
To get the discount please make sure to mention the price match to the customer service team when they call to collect payment for your order. Or call toll free at 1-888-904-8467 to place the order through the phone.
Terms & Conditions of Program
A generic drug is a copy of the brand-name drug with the same dosage, safety, strength, quality, consumption method, performance, and intended use. Before generics become available on the market, the generic company must prove it has the same active ingredients as the brand-name drug and works in the same way and in the same amount of time in the body.
The only differences between generics and their brand-name counterparts is that generics are less expensive and may look slightly different (eg. different shape or color), as trademarks laws prevent a generic from looking exactly like the brand-name drug.
Generics are less expensive because generic manufacturers don't have to invest large sums of money to develop a drug. When the brand-name patent expires, generic companies can manufacture a copy of the brand-name and sell it at a substantial discount.
TRESIBA (insulin degludec) is a long-acting insulin product used to treat high blood sugar (hyperglycemia). TRESIBA is indicated for use in type 1 diabetes mellitus and type 2 diabetes mellitus.
In type 1 diabetes mellitus, patients cannot produce enough of their own insulin. In type 2 diabetes mellitus, patients produce insulin, but their bodies are resistant to the insulin they produce.
TRESIBA is “basal” insulin that provides 24-hour coverage for glycemic control.
TRESIBA is available in or vial or in TRESIBA pens.
The doctor will determine the starting dose of TRESIBA.
Inject TRESIBA insulin subcutaneously once daily at the same time each day.
Rotate injection sites to lower the risk of lipodystrophy.
The active ingredient in TRESIBA is insulin degludec.
Insulin degludec is a long-acting insulin that lasts for about 24 hours in most people.
Some medications can raise or lower blood glucose in people with diabetes. You may be at increased risk of poor glucose control if you take any of the following:
Some drugs can hide the signs and symptoms of hypoglycemia. Use caution if you are taking any of the following:
TRESIBA cannot be used for the treatment of diabetic ketoacidosis.
Do not mix TRESIBA with other insulin products in the same syringe.
Changes to diet, physical activity, or medications may affect blood glucose control.